SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4qpn'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FM6_U_9CRU502_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 12 ALA A 179
LEU A  63
ALA A  59
ILE A  80
LEU A 166
None
0.74A 1fm6U-4qpnA:
undetectable
1fm6U-4qpnA:
21.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F8D_A_BEZA1002_0
(HTH-TYPE
TRANSCRIPTIONAL
REGULATOR BENM)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 10 GLY A 149
LEU A 148
LEU A  82
ILE A  80
ILE A 176
None
1.07A 2f8dA-4qpnA:
undetectable
2f8dA-4qpnA:
21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F8D_B_BEZB1003_0
(HTH-TYPE
TRANSCRIPTIONAL
REGULATOR BENM)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 10 GLY A 149
LEU A 148
LEU A  82
ILE A  80
ILE A 176
None
1.06A 2f8dB-4qpnA:
undetectable
2f8dB-4qpnA:
21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IDW_B_017B401_2
(PROTEASE)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 9 LEU A 109
GLY A  83
ALA A  84
ILE A  80
ILE A 112
None
SAH  A 301 (-3.6A)
None
None
None
0.88A 2idwB-4qpnA:
undetectable
2idwB-4qpnA:
20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QWX_B_ML1B233_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
4 / 7 GLY A 149
GLY A 164
PHE A 191
PHE A 192
None
0.97A 2qwxA-4qpnA:
undetectable
2qwxB-4qpnA:
2.5
2qwxA-4qpnA:
24.41
2qwxB-4qpnA:
24.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKT_B_017B200_1
(PROTEASE)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 9 LEU A 105
ASP A 104
GLY A  85
ALA A  84
GLY A 149
SAH  A 301 (-4.2A)
SAH  A 301 (-2.8A)
SAH  A 301 (-3.3A)
None
None
1.05A 3ektA-4qpnA:
undetectable
3ektA-4qpnA:
19.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKV_A_478A200_1
(PROTEASE)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 10 LEU A 109
GLY A  83
ALA A  84
ILE A  80
ILE A 112
None
SAH  A 301 (-3.6A)
None
None
None
0.81A 3ekvA-4qpnA:
undetectable
3ekvA-4qpnA:
17.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FL9_F_TOPF200_1
(DIHYDROFOLATE
REDUCTASE (DHFR))
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 10 ALA A  93
LEU A 148
VAL A  72
ALA A 179
ILE A 215
None
1.06A 3fl9F-4qpnA:
2.1
3fl9F-4qpnA:
21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3H0A_A_9RAA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 12 ALA A 179
LEU A  63
ALA A  59
ILE A  80
LEU A 166
None
0.73A 3h0aA-4qpnA:
undetectable
3h0aA-4qpnA:
17.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LP9_D_SPMD230_1
(LS-24)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
3 / 3 GLU A 189
GLU A 209
ASN A 212
None
0.90A 3lp9B-4qpnA:
undetectable
3lp9D-4qpnA:
undetectable
3lp9B-4qpnA:
19.69
3lp9D-4qpnA:
19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NU3_B_478B401_2
(PROTEASE)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 11 LEU A 109
GLY A  83
ALA A  84
ILE A  80
ILE A 112
None
SAH  A 301 (-3.6A)
None
None
None
0.78A 3nu3B-4qpnA:
undetectable
3nu3B-4qpnA:
20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NU4_B_478B401_2
(PROTEASE)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 9 LEU A 109
GLY A  83
ALA A  84
ILE A  80
ILE A 112
None
SAH  A 301 (-3.6A)
None
None
None
0.73A 3nu4B-4qpnA:
undetectable
3nu4B-4qpnA:
20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NUJ_B_478B401_2
(PROTEASE)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 9 LEU A 109
GLY A  83
ALA A  84
ILE A  80
ILE A 112
None
SAH  A 301 (-3.6A)
None
None
None
0.73A 3nujB-4qpnA:
undetectable
3nujB-4qpnA:
19.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NUO_B_478B478_2
(PROTEASE)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 9 LEU A 109
GLY A  83
ALA A  84
ILE A  80
ILE A 112
None
SAH  A 301 (-3.6A)
None
None
None
0.77A 3nuoB-4qpnA:
undetectable
3nuoB-4qpnA:
20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OAP_A_9CRA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 12 ALA A 179
LEU A  63
ALA A  59
ILE A  80
LEU A 166
None
0.71A 3oapA-4qpnA:
undetectable
3oapA-4qpnA:
21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DQF_B_017B101_2
(ASPARTYL PROTEASE)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 10 LEU A 109
GLY A  83
ALA A  84
ILE A  80
ILE A 112
None
SAH  A 301 (-3.6A)
None
None
None
0.88A 4dqfB-4qpnA:
undetectable
4dqfB-4qpnA:
20.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LG1_A_SAMA301_0
(PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21D)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
9 / 12 TRP A  57
ALA A  60
GLY A  83
GLY A  85
ASP A 104
LEU A 105
TRP A 133
ALA A 150
TYR A 154
SAH  A 301 (-4.7A)
SAH  A 301 (-3.4A)
SAH  A 301 (-3.6A)
SAH  A 301 (-3.3A)
SAH  A 301 (-2.8A)
SAH  A 301 (-4.2A)
SAH  A 301 (-3.2A)
SAH  A 301 (-3.5A)
SAH  A 301 (-4.4A)
0.43A 4lg1A-4qpnA:
25.8
4lg1A-4qpnA:
32.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LG1_B_SAMB301_0
(PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21D)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
8 / 12 TRP A  57
ALA A  60
GLY A  83
GLY A  85
LEU A 105
TRP A 133
ALA A 150
TYR A 154
SAH  A 301 (-4.7A)
SAH  A 301 (-3.4A)
SAH  A 301 (-3.6A)
SAH  A 301 (-3.3A)
SAH  A 301 (-4.2A)
SAH  A 301 (-3.2A)
SAH  A 301 (-3.5A)
SAH  A 301 (-4.4A)
0.46A 4lg1B-4qpnA:
25.7
4lg1B-4qpnA:
32.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LG1_C_SAMC301_0
(PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21D)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
9 / 12 TRP A  57
ALA A  60
GLY A  83
GLY A  85
ASP A 104
LEU A 105
TRP A 133
ALA A 150
TYR A 154
SAH  A 301 (-4.7A)
SAH  A 301 (-3.4A)
SAH  A 301 (-3.6A)
SAH  A 301 (-3.3A)
SAH  A 301 (-2.8A)
SAH  A 301 (-4.2A)
SAH  A 301 (-3.2A)
SAH  A 301 (-3.5A)
SAH  A 301 (-4.4A)
0.45A 4lg1C-4qpnA:
25.0
4lg1C-4qpnA:
32.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RVJ_B_478B101_2
(HIV-1 PROTEASE)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 9 LEU A 109
GLY A  83
ALA A  84
ILE A  80
ILE A 112
None
SAH  A 301 (-3.6A)
None
None
None
0.76A 4rvjB-4qpnA:
undetectable
4rvjB-4qpnA:
17.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RVJ_D_478D101_2
(HIV-1 PROTEASE)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 9 LEU A 109
GLY A  83
ALA A  84
ILE A  80
ILE A 112
None
SAH  A 301 (-3.6A)
None
None
None
0.75A 4rvjD-4qpnA:
undetectable
4rvjD-4qpnA:
17.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NUK_A_Z80A201_1
(BETA-LACTOGLOBULIN)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 10 ALA A 108
ILE A  91
ILE A  42
VAL A  56
ALA A  53
SAH  A 301 ( 4.9A)
None
None
SAH  A 301 ( 4.2A)
SAH  A 301 (-3.2A)
1.05A 5nukA-4qpnA:
undetectable
5nukA-4qpnA:
18.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6A5Y_D_9CRD501_0
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 12 ALA A 179
LEU A  63
ALA A  59
ILE A  80
LEU A 166
None
0.77A 6a5yD-4qpnA:
undetectable
6a5yD-4qpnA:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6A5Z_D_9CRD501_0
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 12 ALA A 179
LEU A  63
ALA A  59
ILE A  80
LEU A 166
None
0.78A 6a5zD-4qpnA:
undetectable
6a5zD-4qpnA:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6A5Z_L_9CRL501_0
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B

(Homo
sapiens)
5 / 12 ALA A 179
LEU A  63
ALA A  59
ILE A  80
LEU A 166
None
0.79A 6a5zL-4qpnA:
undetectable
6a5zL-4qpnA:
17.14